Kintor Pharmaceutical Limited
KNTPF · OTC
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Market Cap | $1 | $1 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $1 | $0 | $0 | -$0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -67.3% | 0% | – | – |
| Gross Profit | -$0 | -$0 | -$0 | -$0 |
| % Margin | -214.8% | -94.6% | -94.6% | – |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -1,139.2% | -2,567.4% | -2,567.4% | – |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -1,391.5% | -3,105.8% | -3,105.8% | – |
| EPS Diluted | -0.026 | -0.027 | -0.023 | -1.98 |
| % Growth | 2.6% | -17% | 98.8% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |